{"transactions":[{"id":3709621,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2019-01-03T21:10:12.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":19339,"price":3.18,"value":61498.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 16,875 restricted stock units which shall vest in three equal installments on January 1, 2020, 2021 and 2022; (b) a deferred stock award of 54,565 restricted stock units which shall vest in two equal installments on January 1, 2020 and 2021; (c) a deferred stock award of 22,252 restricted stock units which shall vest on January 1, 2020; (d) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 126,613 shares of common stock held by the Reporting Person."}],"balance_after":242805,"source":{"system":"sec-edgar","filing":"0001209191-19-000896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119000896/doc4.xml","form_type":"4"}},{"id":3843650,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Stock option (right to buy)","published_at":"2018-08-15T20:23:22.000Z","date":"2018-08-14","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in four equal installments on each of November 18, 2014, 2015, 2016 and 2017."}],"balance_after":0,"derivative":{"exercise_price":4.31,"expiration_date":"2023-11-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-046795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046795/doc4.xml","form_type":"4"}},{"id":3843649,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-08-15T20:23:22.000Z","date":"2018-08-14","kind":"tax_withholding","acquired":false,"shares":37588,"price":6.65,"value":249960.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 86,488 shares of common stock held by the Reporting Person."}],"balance_after":262144,"source":{"system":"sec-edgar","filing":"0001209191-18-046795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046795/doc4.xml","form_type":"4"}},{"id":3843648,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-08-15T20:23:22.000Z","date":"2018-08-14","kind":"exercise","acquired":true,"shares":50000,"price":4.31,"value":215500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 124,076 shares of common stock held by the Reporting Person."}],"balance_after":299732,"source":{"system":"sec-edgar","filing":"0001209191-18-046795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046795/doc4.xml","form_type":"4"}},{"id":3846333,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-08-13T20:12:09.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":2043,"price":5.7,"value":11645.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person on August 3, 2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 74,076 shares of common stock held by the Reporting Person."}],"balance_after":249732,"source":{"system":"sec-edgar","filing":"0001209191-18-046412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046412/doc4.xml","form_type":"4"}},{"id":3855256,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Stock option (right to buy)","published_at":"2018-08-02T22:57:19.000Z","date":"2018-08-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested in four equal installments on each of November 18, 2014, 2015, 2016 and 2017."}],"balance_after":50000,"derivative":{"exercise_price":4.31,"expiration_date":"2023-11-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-045094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118045094/doc4.xml","form_type":"4"}},{"id":3855255,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-08-02T22:57:19.000Z","date":"2018-08-01","kind":"tax_withholding","acquired":false,"shares":41054,"price":5.75,"value":236060.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (1) and (2) above plus 69,090 shares of common stock held by the Reporting Person."}],"balance_after":258804,"source":{"system":"sec-edgar","filing":"0001209191-18-045094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118045094/doc4.xml","form_type":"4"}},{"id":3855254,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-08-02T22:57:19.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":50000,"price":4.31,"value":215500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; (continued in footnote 2 below)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"(continuation of footnote 1 above) (f) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (g) 110,144 shares of common stock held by the Reporting Person."}],"balance_after":299858,"source":{"system":"sec-edgar","filing":"0001209191-18-045094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118045094/doc4.xml","form_type":"4"}},{"id":3915791,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-05-29T20:36:48.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a deferred stock award of 22,500 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in three equal annual installments on May 24, 2019, May 24, 2020 and May 24, 2021, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from May 24, 2018 to the earlier of (i) May 24, 2019 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) a deferred stock award of 22,500 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (b) all awards and common stock held by Reporting Person as described in footnote 2 above."}],"balance_after":249858,"source":{"system":"sec-edgar","filing":"0001209191-18-033845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118033845/doc4.xml","form_type":"4"}},{"id":3915790,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-05-29T20:36:48.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 22,500 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 60,144 shares of common stock held by the Reporting Person."}],"balance_after":227358,"source":{"system":"sec-edgar","filing":"0001209191-18-033845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118033845/doc4.xml","form_type":"4"}},{"id":4001346,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-03-12T21:35:39.000Z","date":"2018-03-08","kind":"tax_withholding","acquired":false,"shares":2539,"price":4.5,"value":11425.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with unrestricted stock award granted on March 8, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 60,144 shares of common stock held by the Reporting Person."}],"balance_after":204858,"source":{"system":"sec-edgar","filing":"0001209191-18-018918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118018918/doc4.xml","form_type":"4"}},{"id":4001345,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-03-12T21:35:39.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 62,683 shares of common stock held by the Reporting Person."}],"balance_after":207397,"source":{"system":"sec-edgar","filing":"0001209191-18-018918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118018918/doc4.xml","form_type":"4"}},{"id":4108049,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2018-01-04T13:52:28.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":19378,"price":3.3,"value":63947.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 81,847 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 44,503 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 4,306 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 53,795 shares of common stock held by the Reporting Person."}],"balance_after":198509,"source":{"system":"sec-edgar","filing":"0001209191-18-001632","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118001632/doc4.xml","form_type":"4"}},{"id":4301574,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Stock option (right to buy)","published_at":"2017-05-31T00:49:47.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in four equal installments on February 6, 2018, 2019, 2020 and 2021."}],"balance_after":10000,"derivative":{"exercise_price":3.25,"expiration_date":"2027-02-06","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-036311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117036311/doc4.xml","form_type":"4"}},{"id":4301573,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2017-05-31T00:49:47.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":109130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 66,755 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 8,612 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 19,332 shares of common stock held by the Reporting Person."}],"balance_after":217887,"source":{"system":"sec-edgar","filing":"0001209191-17-036311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117036311/doc4.xml","form_type":"4"}},{"id":4503495,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":161381,"kind":"person","name":"Sun Yong","position":1,"cik":"0001592266","reported_name":"Sun Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP - Commercial Operations"}}],"security":"Common Stock","published_at":"2017-01-04T21:38:40.000Z","date":"2017-01-01","kind":"tax_withholding","acquired":false,"shares":9922,"price":3.05,"value":30262.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 66,755 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (b) a deferred stock award of 8,612 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (c) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (d) 19,332 shares of common stock held by the Reporting Person."}],"balance_after":108757,"source":{"system":"sec-edgar","filing":"0001209191-17-000977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117000977/doc4.xml","form_type":"4"}}]}